CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Neoma Labs has developed Sensa, a compact and affordable device for diagnosing obstructive sleep apnea. By measuring jaw movements, it aims to provide a scalable solution to identify undiagnosed patients, significantly reducing healthcare costs associated with untreated sleep apnea.
12% of adults suffer from obstructive sleep apnea (OSA).
Despite the fact that it is a serious disease, it goes undiagnosed 80% of the time.
The cost of undiagnosed OSA patients is €6,000 per person per year whilst the cost of diagnosed patients is only €2,000 per person per year.
Multiplying by around €4,000 that could be saved per diagnosed person, the total savings would be €160 billion/year.Very effective treatment options exist, but the traditional diagnostic infrastructure is neither affor…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
